12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks experienced significant movements. Envoy Medical, Theriva Biologics, and Athira Pharma saw notable gains, while Lexicon Pharmaceuticals and others faced declines. Earnings reports influenced some stock movements.
November 01, 2024 | 12:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biofrontera shares declined by 9.76% to $1.11, with a market cap of $6.1 million.
The decrease suggests negative market sentiment, possibly due to recent unfavorable news or developments.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
bioAffinity Technologies stock fell 9.1% to $1.3, with a market cap of $20.1 million.
The decrease suggests negative market sentiment, possibly due to recent unfavorable news or developments.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Lexicon Pharmaceuticals' stock fell by 39.5% to $1.18, with a market cap of $426.5 million.
The significant drop suggests negative investor sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
Matinas BioPharma Holdings stock declined by 8.07% to $0.57, with a market cap of $2.8 million.
The decline indicates negative investor sentiment, possibly due to recent unfavorable news or developments.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
OneMedNet stock decreased by 10.37% to $0.77, with a market cap of $18.3 million.
The decline indicates negative investor sentiment, possibly due to recent unfavorable news or developments.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Trinity Biotech shares fell 9.1% to $1.6, with a market cap of $15.1 million.
The decline indicates negative investor sentiment, possibly due to recent unfavorable news or developments.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Athira Pharma's stock increased by 26.13% to $0.54, with a market cap of $20.6 million.
The price rise suggests positive market sentiment, potentially due to favorable news or developments.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
ChromaDex shares increased by 16.04% to $4.05 after its Q3 earnings report.
The stock's rise is likely due to positive reception of the Q3 earnings report, indicating strong financial performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Envoy Medical's stock surged by 66% to $4.4, increasing its market cap to $86.8 million.
The significant price increase suggests positive investor sentiment, likely due to favorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Molecular Partners' stock rose 16.79% to $6.26, with a market cap of $230.5 million.
The increase suggests positive investor sentiment, possibly due to recent favorable news or developments.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Pro-Dex stock moved up by 18.06% to $36.62 following its Q1 earnings report.
The stock's rise is likely due to positive reception of the Q1 earnings report, indicating strong financial performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Theriva Biologics shares rose by 43.83% to $2.1, with a market cap of $2.8 million.
The sharp increase indicates strong investor interest, possibly due to recent positive news or developments.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70